The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases. ##STR00001##

 
Web www.patentalert.com

< Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs)

> Bicyclic compounds as modulators of androgen receptor function and method

> Glucagon receptor antagonists, preparation and therapeutic uses

~ 00597